Navigation Links
Covance to Present at William Blair & Company's 29th Annual Growth Stock Conference
Date:6/8/2009

PRINCETON, N.J., June 8 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) today announced that it will present at William Blair & Company's 29th Annual Growth Stock Conference on Tuesday, June 9, 2009 at 4:50 p.m. (ET). Investors may access a live webcast of the presentation at www.covance.com. In order to register and download any necessary software, please log on 10 minutes early.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.7 billion, global operations in more than 25 countries, and more than 9,800 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.


'/>"/>
SOURCE Covance Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Covance Announces Monte Jarvis as Vice President of Global Data Management and Biostatistics for Periapproval Services
2. Covance Recognized for Outstanding Customer Service by Eli Lilly and Company
3. Covance to Present at the Deutsche Bank 34th Annual Health Care Conference
4. Covance To Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
5. Covance To Present at Bairds 2009 Growth Stock Conference
6. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2009 Financial Results Conference Call
7. Covance Central Laboratory Receives CAP Accreditation in China
8. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2009 Financial Results Conference Call
9. Covance Experts to Present Key Insights on Risk Management at Bio/Pharmaceutical Drug Safety Forum
10. Covance to Present at the Barclays Capital Global Healthcare Conference
11. Covance Elects Bradley T. Sheares to Companys Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...reatment advances, study finds , , MONDA... of saliva changes as people age, and better under...e test to diagnose and treat age-related diseases,...umerous proteins that play a role in digestion, fi...re trying to find ways to use these proteins to de...
(Date:11/23/2009)...le age are more than twice as likely to develop de...om the Sahlgrenska Academy. , The study has just...gy . , "Anyone carrying a lot of fat around the ... to a heart attack or stroke," says Deborah Gustaf...If they nevertheless manage to live beyond 70, the...
(Date:11/23/2009)...gia is leading an initiative that could result in ...le cell disease. , Morehouse University School ... in the initiative that is enlisting primary care ...es" for patients, changing how patients are treate...d seeking better prevention and treatment strategi...
(Date:11/23/2009)...ed Strategic Communications Agency Honored by Asso...ls , Salem, MA (PRWEB) No...cused strategic communications agency, announced t...rd in the design/website homepage category adminis...nd Communication Professionals. The MarCom 2009 Aw...
(Date:11/23/2009)...--AnnTaylorStoresCorp.announcedtodaythatitwillretu...ivingcampaign,aholidayfundraisingandawarenessprogr...ksthethirdyearthatAnnTaylor,throughitsANNCARESchar...nwhereweofferourshoppersanopportunitytohelpsavechi...lidayseason.ClientswhoshopatAnnTaylor,Loft,AnnTayl...
Breaking Medicine News(10 mins):Health News:Initiative could result in paradigm shift in the care of sickle cell patients 2Health News:Initiative could result in paradigm shift in the care of sickle cell patients 3Health News:Initiative could result in paradigm shift in the care of sickle cell patients 4Health News:Initiative could result in paradigm shift in the care of sickle cell patients 5Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 2Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 3Health News:Ann Taylor Stores Corp. Returns To St. Jude Children's Research Hospital's Thanks and Giving Campaign(R) For The Third Year 2
...st cancer and inflammatory breast cancer , ...are overweight or obese when diagnosed with locall...ecurrence and a shorter life expectancy than eithe...derweight patients to be diagnosed with a rare, ag...
...esident and Chief Executive Officer,American Lung ... The American Lung,Association salutes the new U.... substantial cuts in the air pollution produced by...lution.,Cleaning up diesel locomotives and marine ...
...ort:, COLORADO SPRINGS, Colo., March 14 Sedentar...ity of life by exercising,as little as 10 to 30 mi...Heart Association,s Conference on Nutrition, Physi...controlled trial,examining the role of exercise in...
...s in developing countries , , FRIDAY, Mar...ing a person,s cardiovascular disease risk, cheap,...ve as lab tests, a new study finds. , The U.S. res...orldwide, about 80 percent of cardiovascular death...
...s in the laboratory suggests that a new compound c... in people infected with the latent form of the ba...ornell Medical College in New York City. A drug wi...o points to new ways of thinking about fighting ba...
...Redondo,Beach, California, had no idea that she wo...s and stop the production of one of the deadliest,...-- asbestos. Reinstein is,executive director and c...asbestos victims and their families., On Saturday...
Other Medicine News:Health News:Obesity Linked to Poor Prognosis for Some Breast Cancer Patients 2Health News:Obesity Linked to Poor Prognosis for Some Breast Cancer Patients 3Health News:Locomotive and Marine Diesel Engines Clean Up Will Save Lives 2Health News:Overweight, Obese Women Improve Quality of Life With 10 to 30 Minutes of Exercise 2Health News:Overweight, Obese Women Improve Quality of Life With 10 to 30 Minutes of Exercise 3Health News:Overweight, Obese Women Improve Quality of Life With 10 to 30 Minutes of Exercise 4Health News:Heart Risk Can Be Predicted Without Lab Tests 2Health News:New chemical can kill latent tuberculosis bacteria 2Health News:New chemical can kill latent tuberculosis bacteria 3Health News:ADAO's March 29 Conference Unites Survivors, Families and Physicians 2Health News:ADAO's March 29 Conference Unites Survivors, Families and Physicians 3Health News:ADAO's March 29 Conference Unites Survivors, Families and Physicians 4Health News:ADAO's March 29 Conference Unites Survivors, Families and Physicians 5Health News:ADAO's March 29 Conference Unites Survivors, Families and Physicians 6
(Date:11/23/2009)...ewswire/--AMDLASERSannouncedthisweekthatitcontinue...ingwithprestigiousindustry-leaderDr.LarryRosenthal...eexclusivesofttissuediodelaserusedduringallinterna...op2%ofdentists. ,, (Photo: http://www.newscom.c...greatpleasurethatIproudlyannounceourpartnership.So...
(Date:11/23/2009)...Newswire-FirstCall/--RaptorPharmaceuticalCorp.("Ra...resultsfromaPhase2bclinicaltrialofitsproprietaryde...npatientswithnephropathiccystinosis("cystinosis")....iego("UCSD")GeneralClinicalResearchCenter,evaluate...namicsofasingledoseofDRCysteamineinninecystinosisp...
(Date:11/23/2009)...v.23 /PRNewswire/-- LaerdalMedical,inalliancewit...secondvolumeofpre-programmedscenariosforusewithLae...sdesignedtointegratesimulationintotheAAP,sNeonatal...tmentofothercriticalmedicalconditionsintheneonatal...n/prnh/20091123/NY14903LOGO ) ,, (Logo: http://...
Breaking Medicine Technology:AMD LASERS Announces New Partnership with Dr. Larry Rosenthal and Aesthetic Advantage 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5Neonatal Scenarios Developed in Partnership with the American Academy of Pediatrics (AAP), Utilize the NRP Curriculum to Advance Newborn Care 2New Jersey Hospital to Pay 243 Million to Resolve Allegations of Medicare Fraud 61648 1New Jersey Hospital to Pay 243 Million to Resolve Allegations of Medicare Fraud 61648 2Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 1Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 2Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 3Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 4Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 5Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 6Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 7Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 8Delcath Systems Announces Completion of Public Offering 6385 1Delcath Systems Announces Completion of Public Offering 6385 2
.... 21 FASgen is pleased to report the,publication ...ield using,FAS89B, one of the Company,s proprietar...search into selective inhibition of fatty acid syn... in the area of metabolic,disease disorders, speci...er disease. The Company has a long-standing cooper...
..., Dec. 20 Novavax, Inc.,(Nasdaq: NVAX ) announce...Ia,human clinical trial of its non-adjuvanted pand...andidate., Penny Heaton, MD, Chief Medical Office...itial results from our Phase I/IIa study are,promi...ic influenza vaccine,through regulatory licensure....
Other Medicine Technology:FASgen Announces a New Discovery in Obesity Research 2Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program 2Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program 3Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program 4
...tient Comfort than chest tubes and Enhanced Ambula...cone drains with four channels along the sides wit...ist of a silicone hub, a silicone extension tubing.../4 fluted (hub outside skin) or full fluted (hub i...
Laparoscopic Introducer Set
Fanelli Laparoscopic Endobiliary Stent Set
Common Duct Exploration Set: With N-Circle® Nitinol Tipless Stone Extractor
Medicine Products: